Sg3 Management, LLC Tg Therapeutics, Inc. Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $89,929 - $167,018	-4,129 Reduced 43.46%	5,371 $179,000
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $178,750 - $269,280	5,500 Added 137.5%	9,500 $369,000
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $336,791 - $439,504	-8,094 Reduced 66.93%	4,000 $193,000
Q3 2020 Nov 13, 2020	BUY	$18.49 - $27.24 $223,618 - $329,440	12,094 New	12,094 $324,000
Q3 2019 Nov 13, 2019	SELL	$5.38 - $8.99 $161,400 - $269,700	-30,000 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$6.27 - $8.65 $188,100 - $259,500	30,000 New	30,000 $260,000

340

88.5M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.09B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.